危重症后成人脓毒症幸存者的健康相关生活质量:系统综述
该系统综述检索OVID MEDLINE、Embase和CINAHL,纳入2009年1月至2024年6月发表的英文研究,评估危重症后90天及以上成人脓毒症幸存者的健康相关生活质量(HRQoL)。从25,611条记录中纳入33项研究,样本量55至2,151例,多数在欧洲进行,EuroQol五维度三水平量表最常用(19项[58%]研究)。综述发现成人脓毒症幸存者危重症后HRQoL低于人群常模,无论随访时间点;脓毒症与非脓毒症幸存者HRQoL无显著差异。纳入研究高偏倚风险主要源于数据缺失和混杂。
要点
- 从25,611条记录中纳入33项研究,样本量55至2,151例,多数在欧洲进行。
- EuroQol五维度三水平量表最常用,19项(58%)研究使用。
- 成人脓毒症幸存者危重症后HRQoL低于人群常模,无论随访时间点。
- 脓毒症与非脓毒症成人幸存者危重症后HRQoL无显著差异。
- 纳入研究高偏倚风险主要源于数据缺失和混杂。
适用人群与场景
- 成人脓毒症幸存者,危重症后90天及以上随访。
- 纳入英文研究,发表时间2009年1月至2024年6月。
研究设计与关键结果
- 系统综述从25,611条记录中纳入33项合格研究,样本量55至2,151例。
- 纳入研究多数在欧洲进行。
- EuroQol五维度三水平量表最常用,19项(58%)研究使用。
- 成人脓毒症幸存者危重症后HRQoL低于人群常模,无论随访时间点。
- 脓毒症与非脓毒症成人幸存者危重症后HRQoL无显著差异。
- 纳入研究高偏倚风险主要源于数据缺失和混杂。
证据类型、等级与局限
- 证据类型:系统综述,检索OVID MEDLINE、Embase和CINAHL,两名评价者独立筛选、提取数据和质量评价,采用Cochrane非随机暴露研究偏倚风险工具评估质量。
- 局限:纳入研究高偏倚风险主要源于数据缺失和混杂。
对床旁实践的改变
- 综述提示成人脓毒症幸存者危重症后HRQoL低于人群常模,无论随访时间点,脓毒症与非脓毒症幸存者间无显著差异。
- 作者认为随着危重症后生存改善,未来研究改善脓毒症后长期HRQoL至关重要。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: As survival following sepsis improves, there is increased attention on the health-related quality of life (HRQoL) of survivors following critical illness. The aim of this study is to systematically review the literature on the HRQoL of adult sepsis survivors following critical illness.
DATA SOURCES: OVID MEDLINE, Embase, and CINAHL were searched using a combination of MeSH subject headings and keywords.
STUDY SELECTION: English-language studies published between January 2009 and June 2024, which investigated the HRQoL of adult sepsis survivors at 90 days or more following critical illness.
DATA EXTRACTION: Extracted data from included studies comprised HRQoL findings, the instruments administered, and representation of adult survivors following critical illness. Risk-of-bias quality assessment was assessed using the Cochrane Risk of Bias In Non-Randomised Studies - of Exposure tool. Selection of studies, data extraction, and quality assessment were conducted independently by two reviewers.
DATA SYNTHESIS: Thrity-three eligible studies were yielded from 25,611 records, with the sample size among included studies ranging from 55 to 2,151 participants. Included studies were mostly conducted in Europe. The EuroQol 5-dimension three-level instrument was most commonly administered (19 [58%] studies). Our review found that adult sepsis survivors following critical illness have lower HRQoL than population norms, regardless of follow-up timepoint. No significant difference was found in the HRQoL of adult survivors following critical illness with or without sepsis. High risk of bias in included studies was mostly due to missing data and confounding.
CONCLUSIONS: As survival following critical illness improves, future research on improving long-term HRQoL following sepsis is crucial.
参考来源
- De Silva S, Urwin A, Grimwood C, et al. Health-Related Quality of Life of Adult Sepsis Survivors Following Critical Illness: A Systematic Review. Crit Care Explor. 2025. PMID: 40138536. doi:10.1097/CCE.0000000000001238
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。